A nationwide cohort study suggests that hepatitis C virus infection is associated with increased risk of chronic kidney disease

Kidney International

Volumn 85, Issue 5, 2014, Pages 1200-1207

  Chen, Yi Chun ^a,b   Lin, Hon Yi ^a,b   Li, Chung Yi ^c,d   Lee, Moon Sing ^a,b   Su, Yu Chieh ^a,b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Chronic kidney disease; Cohort study; Hepatitis C virus infection; Taiwan National Health Insurance Research Database

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEPATITIS C; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; INCIDENCE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; TAIWAN; ADOLESCENT; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTOR; TIME; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; FEMALE; HEPATITIS C; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; TAIWAN; TIME FACTORS; YOUNG ADULT;

EID: 84899960911     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.455     Document Type: Article

References (49)

1. Chen CJ, Wang LY, Chien YC. News from Taiwan. Hepatology 2004; 39: 1196.
2. Hsu CC, Hwang SJ, Wen CP et al. High prevalence and low awareness of CKD in Taiwan: a study on the relationship between serum creatinine and awareness from a nationally representative survey. Am J Kidney Dis 2006; 48: 727-738.
3. Wen CP, Cheng TY, Tsai MK et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008; 371: 2173-2182.
4. Chacko EC, Surrun SK, Mubarack Sani TP et al. Chronic viral hepatitis and chronic kidney disease. Postgrad Med J 2010; 86: 486-492.
5. Meyers CM, Seeff LB, Stehman-Breen CO et al. Hepatitis C and renal disease: an update. Am J Kidney Dis 2003; 42: 631-657.
6. Arase Y, Ikeda K, Murashima N et al. Glomerulonephritis in autopsy cases with hepatitis C virus infection. Intern Med 1998; 37: 836-840.
7. Garcia-Valdecasas J, Bernal C, Garcia F et al. Epidemiology of hepatitis C virus infection in patients with renal disease. J Am Soc Nephrol 1994; 5: 186-192.
8. Soma J, Saito T, Taguma Y et al. High prevalence and adverse effect of hepatitis C virus infection in type II diabetic-related nephropathy. J Am Soc Nephrol 2000; 11: 690-699.
9. Arase Y, Suzuki F, Kawamura Y et al. Development rate of chronic kidney disease in hepatitis C virus patients with advanced fibrosis after interferon therapy. Hepatol Res 2011; 41: 946-954.
10. Butt AA, Wang X, Fried LF. HCV infection and the incidence of CKD. Am J Kidney Dis 2011; 57: 396-402.
11. Tsui JI, Vittinghoff E, Shlipak MG et al. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease. Arch Intern Med 2007; 167: 1271-1276.
12. Moe SM, Pampalone AJ, Ofner S et al. Association of hepatitis C virus infection with prevalence and development of kidney disease. Am J Kidney Dis 2008; 51: 885-892.
13. Asrani SK, Buchanan P, Pinsky B et al. Lack of association between hepatitis C infection and chronic kidney disease. Clin Gastroenterol Hepatol 2010; 8: 79-84.
14. Tsui JI, Vittinghoff E, Shlipak MG et al. Relationship between hepatitis C and chronic kidney disease: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 2006; 17: 1168-1174.
15. Dalrymple LS, Koepsell T, Sampson J et al. Hepatitis C virus infection and the prevalence of renal insufficiency. Clin J Am Soc Nephrol 2007; 2: 715-721.
16. Lee JJ, Lin MY, Yang YH et al. Association of hepatitis C and B virus infection with CKD in an endemic area in Taiwan: a cross-sectional study. Am J Kidney Dis 2010; 56: 23-31.
17. Lin MY, Chiu YW, Lee CH et al. Factors associated with CKD in the elderly and nonelderly population. Clin J Am Soc Nephrol 2013; 8: 33-40.
18. Fabrizi F, Martin P, Dixit V et al. Hepatitis C virus infection and kidney disease: a meta-analysis. Clin J Am Soc Nephrol 2012; 7: 549-557.
19. Harrison SA. Insulin resistance among patients with chronic hepatitis C: etiology and impact on treatment. Clin Gastroenterol Hepatol 2008; 6: 864-876.
20. Sarafidis PA, Ruilope LM. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol 2006; 26: 232-244.
21. Satapathy SK, Lingisetty CS, Williams S. Higher prevalence of chronic kidney disease and shorter renal survival in patients with chronic hepatitis C virus infection. Hepatol Int 2012; 6: 369-378.21.
22. Sheu JJ, Kang JH, Lin HC. Hyperthyroidism and risk of ischemic stroke in young adults: a 5-year follow-up study. Stroke 2010; 41: 961-966.
23. Sun Y, Chang YH, Chen HF et al. Risk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications. Diabetes Care 2012; 35: 1047-1049.
24. Chiu HF, Ho SC, Chang CC et al. Statins are associated with a reduced risk of gastric cancer: a population-based case-control study. Am J Gastroenterol 2011; 106: 2098-2103.
25. Wu CY, Chen YJ, Ho HJ et al. Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection. JAMA 2012; 308: 1906-1914.
26. Ehrlich SF, Quesenberry CP Jr, Van Den Eeden SK et al. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care 2010; 33: 55-60.
27. Liao CC, Su TC, Sung FC et al. Does hepatitis C virus infection increase risk for stroke? A population-based cohort study. PLoS One 2012; 7: e31527.
28. Silbiger SR, Neugarten J. The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 1995; 25: 515-533.
29. Kuo HW, Tsai SS, Tiao MM et al. Epidemiological features of CKD in Taiwan. Am J Kidney Dis 2007; 49: 46-55.
30. Chen YC, Su YC, Lee CC et al. Chronic kidney disease itself is a causal risk factor for stroke beyond traditional cardiovascular risk factors: a nationwide cohort study in Taiwan. PLoS One 2012; 7: e36332.
31. Meguid El Nahas A, Bello AK. Chronic kidney disease: the global challenge. Lancet 2005; 365: 331-340.
32. Upadhyay A, Weiner DE. Lipid-lowering therapy in individuals with CKD: lessons learned from SHARP. Am J Kidney Dis 2012; 59: 170-173.
33. Cases A, Coll E. Dyslipidemia and the progression of renal disease in chronic renal failure patients. Kidney Int 2005; 68(Suppl 99): S87-S93.
34. Bergman S, Accortt N, Turner A et al. Hepatitis C infection is acquired pre-ESRD. Am J Kidney Dis 2005; 45: 684-689.
35. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002; 36(5 Suppl 1): S35-S46.
36. Bakr I, Rekacewicz C, El Hosseiny M et al. Higher clearance of hepatitis C virus infection in females compared with males. Gut 2006; 55: 1183-1187.
37. Mekky RY, Abdelaziz AI. Sex hormones and HCV: an unresolved mystery. Expert Rev Gastroenterol Hepatol 2013; 7: 69-75.
38. Chen J, Muntner P, Hamm LL et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004; 140: 167-174.
39. Tsan YT, Lee CH, Wang JD et al. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection. J Clin Oncol 2012; 30: 623-630.
40. Taiwan Society of Nephrology. Available at http://www.tsn.org.tw, Accessed 3 June 2013.
41. Collins AJ, Foley RN, Herzog C et al. United States Renal Data System 2008 annual data report. Am J Kidney Dis 2009; 53(1 Suppl 1): S1-374.
42. Armstrong GL, Wasley A, Simard EP et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705-714.
43. Lai MN, Lai JN, Chen PC et al. Risks of kidney failure associated with consumption of herbal products containing Mu Tong or Fangchi: a population-based case-control study. Am J Kidney Dis 2010; 55: 507-518.
44. Chen HF, Chen P, Li CY. Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications. Hepatology 2010; 52: 155-163.
45. Lee CC, Su YC, Ho HC et al. Risk of stroke in patients hospitalized for isolated vertigo: a four-year follow-up study. Stroke 2011; 42: 48-52.
46. Bureau of National Health Insurance, Department of Health, Executive Yuan, TaiwanAvailable at. http://www.nhi.gov.twAccessed 3 June 2013.
47. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(2 Suppl 1): S1-266.
48. Collins AJ, Foley RN, Herzog C et al. US Renal Data System 2010 annual data report. Am J Kidney Dis 2011; 57(1 Suppl 1): A8, e1-526.
49. Louie KS St, Laurent S, Forssen UM et al. The high comorbidity burden of the hepatitis C virus infected population in the United States. BMC Infect Dis 2012; 12: 86.